for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

BRIEF-Valneva Partners With Batavia Biosciences For Polio Vaccine

June 15 (Reuters) - VALNEVA SE:

* BATAVIA BIOSCIENCES AND VALNEVA COLLABORATE TO ACCELERATE DEVELOPMENT OF LOW-COST INACTIVATED POLIO VACCINE

* VALNEVA WILL RECEIVE AN UPFRONT PAYMENT AND MONTHLY SERVICE FEES

* TO MANUFACTURE SIPV VACCINE FOR CLINICAL TRIAL PURPOSES IN ITS STATE-OF--ART GMP POLIO MANUFACTURING FACILITY OPERATED UNDER GAPIII POLIO CONTAINMENT

* BATAVIA WILL REMAIN RESPONSIBLE FOR RELEASE AND SUPPLY OF GMP VACCINE TO DCVMS Source text for Eikon: Further company coverage: (Gdansk Newsroom)

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up